Lung Transplantation for Lung-Limited Stage IV NSCLC
The DREAM registry study is investigating whether bilateral lung transplantation can be a viable treatment for patients with stage IV non-small cell lung cancer (NSCLC) that is limited to the lungs. Historically, active cancer was a contraindication for transplant, but new research is exploring if highly selected patients might benefit.
Why it matters
This research could potentially redefine treatment protocols for terminal lung cancer patients who have exhausted traditional systemic therapies.
Breast Cancer GI Cancer Colorectal Cancer GI Cancer Awareness and Advocacy GU Cancer Bladder Cancer Gyn-Onc Uterine Cancer Awareness Month Gynecologic Cancer Awareness Month Hem/Onc Blood Cancer Awareness Month GVHD Leukemia Lymphoma Myeloproliferative Neoplasms Multiple Myeloma Myelodysplastic Syndrome Myelofibrosis Sickle Cell Immunotherapy More Professional Development Patient Voice Lung Cancer Skin Cancer Other Tumor Types News Treatment Menu Home > Lung Cancer > Lung Transplantation for Lung-Limited Stage IV NSCLC
A patient with stage IV non–small cell lung cancer (NSCLC) sits with her oncology team reviewing her latest imaging results. She has exhausted chemotherapy, targeted therapy, immunotherapy, and available clinical trial options. The scans show progressive disease, but with one important distinction: the cancer remains confined to the lungs. As her respiratory symptoms worsen, she asks a difficult question: Could a lung transplant be an option?
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in